Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM
Tobias V. Lanz, R. Camille Brewer, Peggy P. Ho, et al.
Nature (2022) Vol. 603, Iss. 7900, pp. 321-327
Open Access | Times Cited: 584

Showing 1-25 of 584 citing articles:

Unexplained post-acute infection syndromes
Jan Choutka, Viraj Jansari, Mady Hornig, et al.
Nature Medicine (2022) Vol. 28, Iss. 5, pp. 911-923
Open Access | Times Cited: 418
T cells in health and disease
Lina Sun, Yanhong Su, Anjun Jiao, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 346
Epstein–Barr virus and multiple sclerosis
Samantha S. Soldan, Paul M. Lieberman
Nature Reviews Microbiology (2022) Vol. 21, Iss. 1, pp. 51-64
Open Access | Times Cited: 293
Epstein-Barr virus: Biology and clinical disease
Blossom Damania, Shannon C. Kenney, Nancy Raab‐Traub
Cell (2022) Vol. 185, Iss. 20, pp. 3652-3670
Open Access | Times Cited: 235
The immunology of multiple sclerosis
Kathrine E. Attfield, Lise T. Jensen, Max Kaufmann, et al.
Nature reviews. Immunology (2022) Vol. 22, Iss. 12, pp. 734-750
Closed Access | Times Cited: 218
Distinguishing features of Long COVID identified through immune profiling
Jon Klein, Jamie Wood, Jillian R. Jaycox, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 198
Applications of single-cell RNA sequencing in drug discovery and development
Bram Van de Sande, Joon Sang Lee, Euphemia Mutasa-Gottgens, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 6, pp. 496-520
Open Access | Times Cited: 196
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)
Amy D. Proal, Michael B. VanElzakker, Soo Aleman, et al.
Nature Immunology (2023) Vol. 24, Iss. 10, pp. 1616-1627
Open Access | Times Cited: 179
Multiple sclerosis
Dejan Jakimovski, Stefan Bittner, Robert Zivadinov, et al.
The Lancet (2023) Vol. 403, Iss. 10422, pp. 183-202
Closed Access | Times Cited: 173
Human cerebral organoids — a new tool for clinical neurology research
Oliver L. Eichmüller, Juergen A. Knoblich
Nature Reviews Neurology (2022) Vol. 18, Iss. 11, pp. 661-680
Open Access | Times Cited: 167
Chronic viral coinfections differentially affect the likelihood of developing long COVID
Michael J. Peluso, Tyler‐Marie Deveau, Sadie E. Munter, et al.
Journal of Clinical Investigation (2022) Vol. 133, Iss. 3
Open Access | Times Cited: 149
Epstein–Barr virus as a leading cause of multiple sclerosis: mechanisms and implications
Kjetil Bjørnevik, Christian Münz, Jeffrey I. Cohen, et al.
Nature Reviews Neurology (2023)
Closed Access | Times Cited: 130
Gene–environment interactions and their impact on human health
Samuel J. Virolainen, Andrew VonHandorf, Kenyatta C. M. F. Viel, et al.
Genes and Immunity (2022) Vol. 24, Iss. 1, pp. 1-11
Open Access | Times Cited: 128
The link between circulating follicular helper T cells and autoimmunity
Lucy S. K. Walker
Nature reviews. Immunology (2022) Vol. 22, Iss. 9, pp. 567-575
Open Access | Times Cited: 119
Dysregulated naive B cells and de novo autoreactivity in severe COVID-19
Matthew C. Woodruff, Richard P. Ramonell, Natalie S. Haddad, et al.
Nature (2022) Vol. 611, Iss. 7934, pp. 139-147
Open Access | Times Cited: 119
Multiple sclerosis: Neuroimmune crosstalk and therapeutic targeting
Marc Charabati, Michael A. Wheeler, Howard L. Weiner, et al.
Cell (2023) Vol. 186, Iss. 7, pp. 1309-1327
Open Access | Times Cited: 117
The Immunobiology and Pathogenesis of Celiac Disease
Rasmus Iversen, Ludvig M. Sollid
Annual Review of Pathology Mechanisms of Disease (2022) Vol. 18, Iss. 1, pp. 47-70
Open Access | Times Cited: 106
The Role of Viral Infections in the Onset of Autoimmune Diseases
Bhargavi Sundaresan, Fatemeh Shirafkan, Kevin Ripperger, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 782-782
Open Access | Times Cited: 83
Population-Based Estimates for the Prevalence of Multiple Sclerosis in the United States by Race, Ethnicity, Age, Sex, and Geographic Region
Michael Hittle, William J. Culpepper, Annette Langer‐Gould, et al.
JAMA Neurology (2023) Vol. 80, Iss. 7, pp. 693-693
Open Access | Times Cited: 78
Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosis
Hannes Vietzen, S. Berger, Laura M. Kühner, et al.
Cell (2023) Vol. 186, Iss. 26, pp. 5705-5718.e13
Open Access | Times Cited: 78
Advances in Neurodegenerative Diseases
Jeroen Van Schependom, Miguel D’haeseleer
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 1709-1709
Open Access | Times Cited: 77
Neuroinflammation: An astrocyte perspective
Hong‐Gyun Lee, Joon-Hyuk Lee, Lucas E. Flausino, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 721
Open Access | Times Cited: 77
Epstein-Barr virus as a cause of multiple sclerosis: opportunities for prevention and therapy
Francesca Aloisi, Gavin Giovannoni, Marco Salvetti
The Lancet Neurology (2023) Vol. 22, Iss. 4, pp. 338-349
Closed Access | Times Cited: 72
Mis-spliced transcripts generate de novo proteins in TDP-43–related ALS/FTD
Sahba Seddighi, Yue Qi, Anna‐Leigh Brown, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 734
Open Access | Times Cited: 72
Cross-reactive EBNA1 immunity targets alpha-crystallin B and is associated with multiple sclerosis
Olivia G. Thomas, Mattias Bronge, Katarina Tengvall, et al.
Science Advances (2023) Vol. 9, Iss. 20
Open Access | Times Cited: 66
Page 1 - Next Page

Scroll to top